Cannabis companies in Canada have access to tens of millions of dollars worth of financial incentives from provincial and municipal governments – if they know where to look. So far, various levels of government in six provinces have offered incentives to cannabis-related businesses in the form of direct subsidies, tax credits and other financial sweeteners. […]Read More
Get our international newsletter
Germany is on track to become one of the world’s largest medical marijuana markets this year as insured patient numbers soar, MMJ imports rise and the country prepares for domestic cultivation. Some executives also expect recreational legalization to happen “in the foreseeable future.” Germany’s rapid growth is expected to continue independent of the country’s plan […]Read More
A Canadian marijuana company will become the first “pure play” cannabis listing on a major U.S. stock market, an important milestone for the cannabis industry.
Cronos Group, one of Canada’s largest vertically integrated medical marijuana companies, will start trading Tuesday on the Nasdaq Global Market under the symbol CRON. Cronos will maintain its listing on Toronto’s TSX Venture Exchange.Read More
The marijuana industry is fighting a high-stakes court battle to force the Israeli government to approve medical cannabis exports sooner rather than later. The decision by industry advocates to go to court comes as Israeli lawmakers prepare to debate the country’s medical cannabis export policy on Monday. The outcome is huge for dozens of international […]Read More
A bill to regulate the production of medical marijuana in Malta would make the country among the first in the European Union to lay the groundwork for cannabis manufacturing and position it as a supplier in the 28-nation bloc, according to executives and analysts. The Production of Cannabis for Medicinal Use Act, which would apply […]Read More
While Canada and the United States dominated marijuana headlines over the past year, their neighbors in Latin America also made some waves.
Though business and investment opportunities are not nearly as strong as they are in the United States and Canada,?Latin American countries are making progress that paves the way for such opportunities down the road.Read More
The flow of financing and acquisitions involving cross-border marijuana companies is expected to pick up after new?risk-disclosure rules?were unveiled last week that provide greater clarity for Canadian companies with U.S. operations, said analysts and executives. The updated requirements from the Canadian Securities Administrators (CSA) were anticipated after the regulatory group said in January it would […]Read More
Cronos Group unveiled?its Australian joint venture and the first phase of a?10-million-Australian-dollar ($8 million) production facility, the latest move by a Canadian company to carve out opportunities to meet demand Down Under and?position itself to capitalize on future possibilities in Asia. It’s the first Canadian company to help build a medical cannabis company in Australia […]Read More
The cannabis industry is poised for huge growth in 2018 thanks in part to the expected launch of several massive new marijuana markets such as California and Canada, which will generate billions of dollars in sales and create tens of thousands of business opportunities.
The changing business climate will lead to new challenges, struggles and, potentially, failures for companies and the individuals behind them.
As we hurtle into 2018, the editorial staff at Marijuana Business Magazine?– which is published by Marijuana Business Daily – singled out 20 executives in the cannabis space who bear watching in the year ahead.Read More
Mergers and acquisitions in Canada’s marijuana sector are showing no signs of letting up.
The latest deal brings together one of the largest and lowest-cost medical marijuana producers in Canada and a company with an extensive international footprint.Read More
A proposed excise tax on medical marijuana in Canada could push even more patients to the black market and curb demand in the regulated market, executives, economists and patients told Marijuana Business Daily. The federal government plans to apply the same 10%?excise tax on medical users as recreational users. That’s on top of provincial and […]Read More